Sonoma Pharmaceuticals, Inc. Business Finance Contracts & Agreements

74 Contracts & Agreements

Browse by Subcategory

Equity Distribution Agreements (2 contracts)
Funding Agreements (1)
Loan Agreements (2)
Purchase Agreements (17)
Registration Rights Agreements (2)
Security Agreements (4)
Stock Agreements (12)
Underwriting Agreements (6)
Warrant Agreements (28)

Recent Contracts

Amendment No. 1 to Equity Distribution Agreement, by and between Sonoma Pharmaceuticals, Inc. and Maxim Group LLC., dated March 8, 2024 (Filed With SEC on March 8, 2024)
Equity Distribution Agreement, by and between Sonoma Pharmaceuticals, Inc. and Maxim Group LLC., dated December 15, 2023 (Filed With SEC on December 18, 2023)
Form of Securities Purchase Agreement (Filed With SEC on October 13, 2023)
SONOMA PHARMACEUTICALS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM AND STOCK OWNERSHIP GUIDELINES Revised by the Board of Directors on December29, 2022 (Filed With SEC on December 30, 2022)
Asset Purchase Agreement between Sonoma Pharmaceuticals, Inc. and Infinity Labs SD Inc., dated June 24, 2020 (Filed With SEC on June 29, 2020)
Asset Purchase Agreement dated February 21, 2020, between Sonoma Pharmaceuticals, Inc. and Microsafe Group, DMCC (Filed With SEC on February 27, 2020)
Form of Placement Agent Warrant granted to Dawson James Securities, Inc. in connection with the November 2019 public offering (Filed With SEC on November 29, 2019)
Asset Purchase Agreement dated May 14, 2019, between Sonoma Pharmaceuticals, Inc. and Petagon, Ltd (Filed With SEC on May 22, 2019)
Warrant Agency Agreement by and among Sonoma Pharmaceuticals, Inc. and Computershare, Inc. and Computershare Trust Company, N.A., dated November 21, 2018 (Filed With SEC on November 21, 2018)
Form of Unit Purchase Option (Filed With SEC on November 21, 2018)
Form of Series C Warrant (Filed With SEC on November 21, 2018)
Form of Warrant Agency Agreement (Filed With SEC on November 16, 2018)
Form of Representative's Unit Purchase Option (Filed With SEC on November 16, 2018)
Form of Series C Warrant (Filed With SEC on November 16, 2018)
Form of Series C Warrant (Filed With SEC on November 7, 2018)
Securities Purchase Agreement entered into by and between Sonoma Pharmaceuticals, Inc. and Montreux Equity Partners V, L.P., dated March 1, 2018 (Filed With SEC on March 6, 2018)
Form of Placement Agent Warrant granted to Dawson James Securities, Inc. and The Benchmark Company, LLC in connection with the March 2, 2018 public offering, dated March 6, 2018 (Filed With SEC on March 6, 2018)
Specimen Common Stock Certificate (Filed With SEC on June 28, 2017)
SECTION 382 RIGHTS AGREEMENT dated as of October 18, 2016 between OCULUS INNOVATIVE SCIENCES, INC. and COMPUTERSHARE INC., as Rights Agent (Filed With SEC on October 21, 2016)
COMMON SHARE PURCHASE WARRANT OCULUSINNOVATIVE SCIENCES, INC. (Filed With SEC on June 21, 2016)
OCULUS INNOVATIVE SCIENCES, INC. and COMPUTERSHAREINC. and ComputershareTRUST COMPANY, N.A. WARRANT AGREEMENT Dated as of March 18, 2016 (Filed With SEC on March 18, 2016)
UNDERWRITING AGREEMENT By and between OCULUS INNOVATIVE SCIENCES, INC. and DAWSON JAMES SECURITIES, INC., asRepresentative of the Several Underwriters (Filed With SEC on March 18, 2016)
SECURITIES PURCHASE AGREEMENT (Filed With SEC on March 16, 2015)
SECURITIES PURCHASE Follow-UpAGREEMENT (Filed With SEC on March 16, 2015)
COMMON STOCK PURCHASE WARRANT OCULUSINNOVATIVE SCIENCES, INC. (Filed With SEC on January 26, 2015)
COMMON STOCK PURCHASE WARRANT OCULUSINNOVATIVE SCIENCES, INC. (Filed With SEC on January 26, 2015)
COMMON STOCK PURCHASE WARRANT OCULUSINNOVATIVE SCIENCES, INC. (Filed With SEC on January 26, 2015)
COMMON STOCK PURCHASE WARRANT OCULUSINNOVATIVE SCIENCES, INC. (Filed With SEC on January 26, 2015)
COMMON STOCK PURCHASE WARRANT OCULUSINNOVATIVE SCIENCES, INC. (Filed With SEC on January 26, 2015)
OCULUS INNOVATIVE SCIENCES, INC. and COMPUTERSHAREINC. and ComputershareTRUST COMPANY, N.A. WARRANT AGREEMENT Dated as of January 20, 2015 (Filed With SEC on January 26, 2015)
OCULUS INNOVATIVE SCIENCES, INC. UNDERWRITING AGREEMENT January 20, 2015 (Filed With SEC on January 26, 2015)
OCULUS INNOVATIVE SCIENCES, INC. UNDERWRITING AGREEMENT January ___,2015 (Filed With SEC on January 20, 2015)
OCULUS INNOVATIVE SCIENCES, INC. And COMPUTERSHAREINC. And ComputershareTRUST COMPANY, N.A. WARRANT AGREEMENT Dated as of [________], 2015 (Filed With SEC on January 16, 2015)
OCULUS INNOVATIVE SCIENCES, INC. And COMPUTERSHAREINC. And ComputershareTRUST COMPANY, N.A. WARRANT AGREEMENT Dated as of [________], 2015 (Filed With SEC on January 13, 2015)
OCULUS INNOVATIVE SCIENCES, INC. UNDERWRITING AGREEMENT [____________], 2015 (Filed With SEC on January 13, 2015)
SECURITIES PURCHASE AGREEMENT (Filed With SEC on January 12, 2015)
COMMON STOCK PURCHASE WARRANT OCULUSINNOVATIVE SCIENCES, INC. (Filed With SEC on January 7, 2015)
OCULUS INNOVATIVE SCIENCES, INC. and COMPUTERSHAREINC. and ComputershareTRUST COMPANY, N.A. WARRANT AGREEMENT Dated as of [_____________], 2015 (Filed With SEC on January 7, 2015)
OCULUS INNOVATIVE SCIENCES, INC. UNDERWRITING AGREEMENT [____________], 2015 (Filed With SEC on January 7, 2015)
OCULUS INNOVATIVE SCIENCES, INC. Common Stock (par value $0.0001 per share) At-the-Market Issuance Sales Agreement (Filed With SEC on April 2, 2014)